Dr. Peter Brian-Andersson - Board Certified Neurologist

Dr. Andersson, a Board Certified Neurologist and UCLA Associate Professor, specializes in traumatic brain injury, multiple sclerosis, complex regional pain syndrome, capacity, headaches, memory disorders, and nursing home standard of care. Between 1992 and 1997, he completed an internal medicine internship and then neurology residency at the University of California, San Francisco where he also served as Chief Resident. He has completed fellowships in multiple sclerosis at UCSF and in neuromuscular disease at Stanford University. He served on the faculty at Stanford University in the neuromuscular division before moving to the Valley in 1999 and has served this community as both an outpatient and inpatient neurologist for over 20 years.

Prior to beginning his residency, Dr. Andersson graduated cum laude in medicine from the University of Cape Town in 1986. In 1988, he earned an honors degree in medical biochemistry at the University of Cape Town. Between 1988 and 1991, Dr. Andersson obtained a D. Phil in neuroimmunology at Oxford University as a Rhodes Scholar. He was Yamanouchi Junior Research Fellow in Cell Biology at Wolfson 1991-2. Junior Research Fellowships are awarded to the top 2% of graduates at Oxford University.

Dr. Andersson has served his community as an outpatient and inpatient neurologist for over 20 years. He has been published in laboratory and clinical neurology. He has been an ad hoc reviewer for the journal Muscle & Nerve. He is the Medical Director of Stratus Neurodiagnostics, the leading outpatient EEG services company in the U.S. He has served as a Principal and Co-Investigator for dementia trials at The National Research Institute.

Services

Medical-legal evaluation, IME's, and consultation related to traumatic brain injury, multiple sclerosis, complex regional pain syndrome, capacity, headaches, memory disorders, testamentary capacity, personal injury, employment capacity, and nursing home standard of care

Areas of Expertise

Additional Expertise:

Complex Regional Pain Syndrome; Neuromuscular Disorders; Electroencephalogram (EEG); Electromyogram (EMG); Nerve Conduction (NCS); Nursing Home Standard of Care.

Profile

The Pacific Forensic Group is uniquely positioned to address the majority of forensic issues involving the brain, psychological functioning and behavior.

Our group of colleagues include:
-Dr. Peter Brian Andersson, Board Certified Neurologist, Specializing in Traumatic Brain Injury, Neurocognitive Disorders, Multiple Sclerosis
-Dr. Charles Filanosky, Board Certified Rehabilitation Psychologist, Specializing in Traumatic Brain Injury, PTSD
-Dr. David Contreras, Board Certified Forensic Psychologist, Specializing in Juvenile Competency to Stand Trial, Transfer/Waiver to Adult Court, Juvenile Sexual Offenses
-Dr. Lisa Kalich, Board Certified Forensic Psychologist, Specializing in Personal Injury, Parenting Capacity, Sexual Offender and Violence Risk Assessment for Adults and Juveniles, Disability, Child Witness Issues.
-Dr. Jerry Lockhart, Board Certified Forensic Psychologist, Bilingual (Spanish-English Specializing in Juvenile Competency and Immigration Evaluations
-Dr. Laurel Mattos, Forensic Psychologist, Specializing in Trial Competency, NGRI, Mental Health Diversion, Violence Risk Assessment
-Dr. Elise Yenne, Forensic Psychologist, Specializing in Juvenile and Adult Trial Competency, Violence Risk Assessment Transfer Hearings
-Dr. Trayci Dahl, Board Certified Forensic Psychologist, Specializing in Filicide, Capital Sentencing, and Threat Assessment
-Dr. Mario Souza, Bilingual (Spanish-English) Forensic Psychologist, Specializing in Violence Risk, Sex Offender Risk, Insanity, Mitigation, and Mental Health Diversion

The Pacific Forensic Group is unique in having two experts who conduct evaluations in Spanish. We are available for in person and zoom forensic evaluations depending upon the case specifics. Please utilize our website to learn more about our forensic and medical-legal services the civil, criminal, probate, and employment arenas.

Areas Served

All states

Professional Experience

Current Hospital Privileges:

Providence-Cedars Sinai Tarzana Medical Center Oct 2000-Present

Principal Positions Held:

University of Cape Town
Oct 1983-Oct 1984: Vice President, Medical Students Council
Oct 1984-Oct 1985: Chairman, Medical Residence
Jan-Dec 1987: Intern in Medicine, Surgery and ObGyn (4 months each)
Jan-Oct 1988: Researcher, Medical Research Council Regulatory Neuropeptides Unit

University of Oxford
Oct 1988-Oct 1989: Tutor in Pathology, New College and St. Hilda's College
Oct 1989-Jun 1992: College Lecturer in Immunology, Christ Church
Jun 1991-Jun 1992: Yamanouchi Junior Research Fellow in Cell Biology, Wolfson College

University of California, San Francisco
Jul 1992-Jun 1993: Intern in Internal Medicine
Jul 1993-Jun 1995: Resident in Neurology
Jul 1995-Jun 1996: Chief Resident in Neurology
Jul 1996-Aug 1997: Clinical Instructor & Multiple Sclerosis Fellow

Oregon Health Sciences University
Jun 1998-Aug 1998: Senior Instructor & Neuromuscular Fellow

Stanford University & Forbes Norris MDA/ALS Center
Aug 1998-Jun 1999: Neuromuscular Fellow
Jul 1999-Nov 1999: Clinical Instructor

Kaiser Permanente Woodland Hills Medical Center
Nov 1999-Oct 2000: Staff Neurologist

Neurology Private Practice
San Fernando Valley Neurologic Medical Group, Inc. Oct 2000-Jun 2017
Clinical Assistant Professor in Neurology UCLA 2001-2007
Clinical Associate Professor in Neurology UCLA 2008-present
Founder and CEO, Neurology Consulting, Inc. Jul 2017-Present
Stroke Program Co-Director, Tarzana Hospital 2011-2015
Co-Investigator examining physician IDEAS Study 2016-2017
Co-investigator examining physician National Research Institute XanADu Trial 2017-2019
Co-Investigator National Research Institute Lilly LDMC Study 2019
Principal Investigator National Research Institute T3D-959 Study 2019-Present
Medical Director for California, Alliance Neurodiagnostics 2018-Present
Medical Director, California Neurodiagnostics 2018-Present
Contracted speaker for Eli Lilly, Inc. 2017, 2019-Present
Contracted speaker for Biohaven Pharmaceuticals 2021

Licenses

California - 1993 to present (#A52853)
Oregon - 1998 to present (#20964 – inactive)
United Kingdom - 1988 to present (#3372254 - inactive)
South Africa - 1987 to present (#MP30729 - inactive)

Affiliations

American Academy of Neurology
American Association of Electrodiagnostic Medicine
American Medical Association

Qualifications

Board Certified in Clinical Neurophysiology, American Board of Psychiatry and Neurology, 2001
Board Certified in Clinical Neurophysiology, American Board of Electrodiagnostic Medicine, 2000
Board Certified in Neurology, American Board of Psychiatry and Neurology, 1998

Awards & Honors

17th place South African National Science Olympiad 1980
12th highest school-leaving examination results out of the 6155 candidates in State
Harry Allschwang Merit Scholarship, University of Cape Town 1981-1986
Class Gold Medalist (Top Student) in ObGyn final examinations, University of Cape Town 1986
MB.Ch.B. degree awarded cum laude, University of Cape Town 1986
Medical Research Council Post-Intern Scholar, University of Cape Town 1987
Harry Crossley Study Grant, University of Cape Town 1987
Rhodes Scholar 1988-1991
G.A. Paul Memorial Scholar, University College, University of Oxford 1991-1992
Yamanouchi Junior Research Fellow, Wolfson College, University of Oxford 1991-1992
UCSF School of Medicine Class of 1995 Resident Teaching Award
UCSF School of Medicine Class of 1996 Resident Teaching Award
UCSF Chief Resident in Neurology, 1995-1996
Marquis Who's Who in America Science and Engineering 1996-7
Elected to Alpha Omega Alpha Honor Society by UCSF School of Medicine Class of 1997
Fellow, American Board of Electrodiagnostic Medicine, 2000
Ad Hoc Reviewer Muscle & Nerve
UCLA School of Medicine Neurology Department Outstanding Medical Student Teaching Award, 2006
UCLA School of Medicine Outstanding Tutor Award yearly 2007-10, 2012, 2014, 2015
UCLA School of Medicine Neurology Department Teaching Award, 2011
Golden Hammer Resident Teaching Award, Department of Neurology UCLA 2008
Southern California Super Doctors 2010-2021 Los Angeles Magazine, SuperDoctors.com
Noticed Expert Network Distinguished Physician, 2017
The Leading Physicians of the World Directory, 2018

Seminars & Training

Invited speaker, British Society of Toxicological Pathologists Autumn meeting, Royal Society of Medicine, London, 8th November, 1991.
Invited discussant, "Neurological Consequences of Immune Dysregulation - Lessons from HIV and MS" National MS Society workshop, Sanibel Island, Florida, U.S.A., 18-21 January 1992
Invited speaker, "Macrophage and microglial responses in CNS inflammation”. Neuromodulation in Pharmacology conference, Institut Pasteur, Paris, 5-7 February 1992.
Invited speaker, UCSF CNS Injury and Edema Research Centre and Neonatal Brain Disorders Centre, 2 November 1994.
UCSF Department of Neurology Grand Rounds “Neuroimmunomodulation with IVIG” October 16, 1996.
Invited Speaker, National Multiple Sclerosis Society Northern California Chapter Annual General Meeting, Sacramento, August 23, 1996, Seattle Chapter Annual General Meeting, Seattle, October 19,1996 and Southern California Chapter Meeting, Los Angeles, November 17,1996.
49th American Academy of Neurology meeting, "Primary progressive MS: clinical characteristics and progression of disability" (poster). Boston, April 12-19,1997.
Invited speaker, "A phase IV study of interferon-1a (Avonex®) for relapsing remitting MS". National launch of interferon beta 1-a, Dublin, Ireland, 12th November 1997.
Platform presentation 51st American Academy of Neurology Meeting, “Differentiating electrophysiological characteristics of Hereditary neuropathy with liability to pressure palsy” Toronto, April 18-25, 1999.
Clinical case presenter, Neuromuscular evening seminar, 51st Annual American Academy of Neurology meeting, Toronto, April 23, 1999
Invited speaker, “Update in Multiple Sclerosis Therapies”, National Multiple Sclerosis Society, Universal Hilton Hotel, Los Angeles, June 2, 2001
Invited speaker, “The Neurological Examination” Encino-Tarzana Medical Center Grand Rounds, April 2004
Invited speaker, “Neuromuscular Junction Disease”, Resident Lecture, UCLA Medical Center Nov 17, 2004
Invited speaker, “Peripheral Neuropathy”, Medical Student Lecture, UCLA Medical Center 2006-12
Invited speaker, “Stroke update”, Providence Tarzana Medical Center Community Lecture 2011-15
Invited speaker, “The Problem of Dementia” Forum hosted at Calvary Community Church, Westlake Aug 16, 2014
Invited speaker, “Complex Regional Pain Syndrome” AAA Adjustors Meeting, City of Industry Dec 11, 2019

Publications

1. King JA, Davidson J, Mehl AI, Wakefield IK, Andersson P-B and Millar RP (1989) Gonadal steroid modulation of signal transduction and luteinising hormone release in cultured chicken pituitary cells. Endocrinology 124, 1830-1840.
2. Hudson DA, Andersson P-B, Krige JE and Terblanche J (1990) Perihepatic packing in liver rupture during pregnancy. Journal of Obstetrics and Gynaecology 9, 298-299.
3. Andersson P-B, Perry VH and Gordon S (1991) The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience 42, 201-214.
4. Andersson P-B., Perry V. H. and Gordon S. (1991) The CNS acute inflammatory response to excitotoxic neuronal cell death. Immunology Letters 30, 177-183.
5. Andersson P-B, Perry V.H. and Gordon S. (1992) The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 48, 169-186.
6. Perry V.H. and Andersson P-B. (1992) The inflammatory response in the CNS. Neuropathology and Applied Neurobiology 18, 454-459.
7. Andersson P-B., Perry V.H. and Gordon S. (1992) Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. Journal of Experimental Medicine 176, 255-259.
8. Perry V.H., Andersson P-B and Gordon S. (1993) Macrophages and inflammation in the central nervous system. Trends in the Neurosciences 16, 268-273.
9. Reid D.M., Perry V.H., Andersson P-B and Gordon S. (1993) Mitosis and apoptosis of microglia in vivo induced by an anti-CR3 antibody which crosses the blood-brain barrier. Neuroscience 56, 529-233.
10. Andersson P-B and Goodkin D.E. (1996) Current Pharmacologic Treatment of Multiple Sclerosis Symptoms. Western J. Medicine 165:313-317.
11. Andersson P-B, Waubant E and Goodkin D.E. (1997) How should we proceed with disease- modifying treatments for multiple sclerosis? Lancet. 349:586-587.
12. Andersson P-B and Goodkin DE (1997) Outcomes assessment in multiple sclerosis. In Bailliere's Clinical Neurology. Vol 6 Multiple Sclerosis, Miller DH (ed). Bailliere Tindall, London. pp 409-428
13. Andersson P-B and Goodkin DE (1997) Glucocorticosteroid therapy for multiple sclerosis: a critical review. Journal of the Neurological Sciences.16:16-25.
14. Andersson P-B, Waubant E, Gee L, Goodkin DE (1999) Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability. Archives of Neurology. 56:1138-1142
15. Waubant E, Goodkin DE, Sloan R, Andersson P-B, (1999) A pilot study of MRI activity before and during interferon beta-1a therapy. Neurology. 53: 874-876
16. Waubant E, Gee L, Sloan R, Rooney W, Andersson P-B, Stewart T, Vermathen M, Stabler G, Miller K, Goodkin D (1999) Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology 53:1397-1401
17. Waubant E, Sloan R, Andersson P-B, Goodkin D.E. (1999) [Effect of weekly intramuscular interferon beta 1-a on MRI lesions in patients with relapsing multiple sclerosis].Rev Neurol (Paris) 155 Sup 2 S20-23.
18. Andersson P-B, Rando T. (1999) Childhood Neuromuscular diseases. Current Opinion in Pediatrics. 11:497-503.
19. Katz JS, Wolfe GI, Andersson P-B, Saperstein DS, Elliot JL, Nations SP, Bryan WW, Barohn RJ (1999) Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology 53:1071-1076.
20. Suhy J, Rooney WD, Goodkin DE, Capizzano AA, Maudsley AA, Waubant E, Andersson P-B, Weiner MW (2000) 1H-MRS of normal appearing white matter and lesions in primary progressive MS: comparison with relapsing remitting MS. Multiple Sclerosis 6:148-155
21 Goodkin DE, Shulman M, Winkelhake J, Waubant E, Andersson P-B, Stewart T, Nelson S, Fischbein N, Coyle PK, Frohman E, Jacobs L, Holcenberg J, Lee M, Mocci S. (2000) A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis. Neurology. 54:1414-20.
22. Tregoning SK, Ballard RC, Andersson P-B, Fehler HG, van der Spuy ZM (2000) Antibodies to Chlymadia trachomatis in patients presenting with ectopic pregnancy at Groote Schuur Hospital. S Afr Med. J. 90:727-730
23. Andersson P-B, Yuen E, Katz JS, Parko K, So, YT (2000) The differentiating electrophysiologic characteristics of hereditary neuropathy with liability to pressure palsy. Neurology. 54:40-44.
24. Lin P.T., Andersson P-B, Distad BJ, Barohn RJ, Cho SC, So YT, Katz JS (2005) Bilateral phrenic neuropathy causing painless bilateral diaphragmatic paralysis. Neurology 65:499-501

Books and Monographs

1. Perry V.H., Andersson P-B, Coffey P.J. and Gordon S. (1992) Macrophage- microglial responses to excitotoxin-induced degeneration in the central nervous system. In Mononuclear phagocytes: biology of monocytes and macrophages (ed. R. van Furth). Kluwer Academic, Netherlands, pp 35-44.
2. Perry V.H., Brown M.C. & Andersson P-B. (1992) Macrophage responses to central and peripheral nerve injury. In Advances in Neurology Vol 59 (ed F.J. Seil) Raven Press, Ltd, New York, pp 309-314.
3. Perry V.H., Brown M.C. & Andersson P-B (1993) Manipulating macrophages in nervous system repair. In Neuronal Cell Death and Repair. A.C. Cuello (ed). Elsevier Science Publishers, 193-199.
4. Goodkin D.E., Shulman M., Winkelhake J, Waubant E., Andersson, P-B, Stewart T., Nelson S, Fischbein N, Coyle P.K., Frohmann E, Jacobs L, Holcenberg J, Lee M & Mocci, S. (2001) A Phase I trial of solubilized DR2:MBP (84-102) (AG284 in multiple sclerosis. In Multiple Sclerosis: Tissue Destruction and Repari. Kappos L, Johnson K. Informa Health Care, 337-9.

Education

University of Cape Town
Oct 1983-Oct 1984: Vice President, Medical Students Council
Oct 1984-Oct 1985: Chairman, Medical Residence
Jan-Dec 1987: Intern in Medicine, Surgery and ObGyn (4 months each)
Jan-Oct 1988: Researcher, Medical Research Council Regulatory Neuropeptides Unit

University of Oxford
Oct 1988-Oct 1989: Tutor in Pathology, New College and St. Hilda's College
Oct 1989-Jun 1992: College Lecturer in Immunology, Christ Church
Jun 1991-Jun 1992: Yamanouchi Junior Research Fellow in Cell Biology, Wolfson College

University of California, San Francisco
Jul 1992-Jun 1993: Intern in Internal Medicine
Jul 1993-Jun 1995: Resident in Neurology
Jul 1995-Jun 1996: Chief Resident in Neurology
Jul 1996-Aug 1997: Clinical Instructor & Multiple Sclerosis Fellow